These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4718666)

  • 1. Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.
    Sladek NE
    Cancer Res; 1973 Jun; 33(6):1150-8. PubMed ID: 4718666
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic efficacy of cyclophosphamide as a function of its metabolism.
    Sladek NE
    Cancer Res; 1972 Mar; 32(3):535-42. PubMed ID: 5061308
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic efficacy of cyclophosphamide as a function of inhibition of its metabolism.
    Sladek NE
    Cancer Res; 1972 Sep; 32(9):1848-54. PubMed ID: 4641276
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenobarbital effects on cyclophosphamide pharmacokinetics in man.
    Jao JY; Jusko WJ; Cohen JL
    Cancer Res; 1972 Dec; 32(12):2761-4. PubMed ID: 4678592
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
    Gurtoo HL; Hipkens JH; Sharma SD
    Cancer Res; 1981 Sep; 41(9 Pt 1):3584-91. PubMed ID: 7260917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect.
    Donelli MG; Bartosek I; Guaitani A; Martini A; Colombo T; Pacciarini MA; Modica R
    Cancer Treat Rep; 1976 Apr; 60(4):395-401. PubMed ID: 1277213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enzymatic basis of the selective action of cyclophosphamide.
    Cox PJ; Phillips BJ; Thomas P
    Cancer Res; 1975 Dec; 35(12):3755-61. PubMed ID: 172233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsomal activation of cyclophosphamide in vivo.
    Connors TA; Grover PL; McLoughlin AM
    Biochem Pharmacol; 1970 Apr; 19(4):1533-5. PubMed ID: 4398015
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
    Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
    J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolation and identification of a metabolic intermediate in the selective dechloroethylation of one of the four stereoisomers of 4-methylcyclophosphamide.
    Abel G; Cox PJ; Farmer PB; Haskins NJ; Jarman M; Meral K; Stec WJ
    Cancer Res; 1978 Aug; 38(8):2592-9. PubMed ID: 667853
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behaviour of clostridial antibodies in rats with transplantable tumours under therapy by cyclophosphamide (author's transl)].
    Kretschmer H; Hambsch K; Ludewig R
    Arch Geschwulstforsch; 1974; 44(2):103-5. PubMed ID: 4471604
    [No Abstract]   [Full Text] [Related]  

  • 13. [Animal experiments on the effect of vitamin A on Walker carcinoma of the rat].
    Prignitz R; Schulz B; Pfab R; Buchelt L; Neumann H
    Strahlentherapie; 1973 Jan; 145(1):88-100. PubMed ID: 4348296
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity.
    Sladek NE; Smith PC; Bratt PM; Low JE; Powers JF; Borch RF; Coveney JR
    Cancer Treat Rep; 1982 Nov; 66(11):1889-1900. PubMed ID: 7139634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of cyclophosphamide and 6-mercaptopurine metabolic rates in perfused liver of normal and tumour-bearing animals.
    Bartosek I; Donelli MG; Guaitani A; Colombo T; Russo R; Garattini S
    Biochem Pharmacol; 1975 Jan; 24(2):289-90. PubMed ID: 1111539
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of cyclophosphamide and 2,3,5-tris-ethyleniminobenzoquinone-(1,4) on tumor cells in diffusion chambers].
    Teichmann B
    Arzneimittelforschung; 1965 May; 15(5):532-4. PubMed ID: 5898339
    [No Abstract]   [Full Text] [Related]  

  • 17. [A method of primary selection of antitumor agents].
    Karaivanova MKh
    Vopr Onkol; 1971; 17(2):62-6. PubMed ID: 5567711
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
    Parkanskiĭ MN; Konovalova NP; Emanuél' N
    Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450.
    Hales BF
    Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.